dabigatran etexilate 150 MG Oral Capsule

RxCUI: 1037045
RxNorm name: dabigatran etexilate 150 MG Oral Capsule
Display name: dabigatran etexilate 150 MG Oral Capsule
Full name: dabigatran etexilate 150 MG Oral Capsule
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 18 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Dabigatran Etexilate	DABIGATRAN ETEXILATE	Ascend Laboratories, LLC	3a8ec82a-c367-40dc-9302-e1896fcb05ea	2026-08-03	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
DABIGATRAN	DABIGATRAN ETEXILATE	American Health Packaging	f7ea7e2c-ca54-4ecc-9fc7-bd3571b0ebc2	2026-07-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
dabigatran etexilate	DABIGATRAN ETEXILATE	Apotex Corp.	dd47a015-ff90-d7a7-8dcb-4e6e31a68071	2026-07-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
DABIGATRAN	DABIGATRAN ETEXILATE	Novadoz Pharmaceuticals LLC	6f79088b-b353-485a-9df4-6f5088f5bd0f	2026-02-06	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
DABIGATRAN	DABIGATRAN ETEXILATE	AvKARE	27e95caf-7938-ef8e-e063-6394a90a6a1a	2026-01-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	NorthStar RxLLC	d5937f27-88c7-4c4a-801e-4c8945008982	2025-12-03	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	Alembic Pharmaceuticals Limited	13649035-a498-4e31-a7ea-8b18cedceca7	2025-11-20	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
DABIGATRAN	DABIGATRAN ETEXILATE	AvPAK	39ac558a-b375-f3c1-e063-6394a90aa901	2025-11-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	Alembic Pharmaceuticals Inc.	834a3c5f-b723-4bcb-a560-dc305dd0d829	2025-10-31	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	A-S Medication Solutions	369b945d-5bda-4773-910a-d0adef7f0f39	2025-09-19	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
DABIGATRAN ETEXILATE	DABIGATRAN ETEXILATE	Aurobindo Pharma Limited	5b196b1f-408e-4615-b980-9f822adff835	2025-08-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	Camber Pharmaceuticals, Inc.	3c24e235-218b-438e-9456-42c18ff01913	2025-07-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	Mylan Pharmaceuticals Inc.	baafb5be-ffe6-4755-a7ab-817b3c9b222d	2025-07-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran etexilate	DABIGATRAN ETEXILATE	Dr.Reddys Laboratories Inc	a608e019-db9a-d6fb-cd0d-cecc1351a2b1	2025-07-24	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Pradaxa	DABIGATRAN ETEXILATE MESYLATE	Boehringer Ingelheim Pharmaceuticals Inc.	ba74e3cd-b06f-4145-b284-5fd6b84ff3c9	2025-06-25	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	Major Pharmaceuticals	b76b79ce-b7dd-4390-b40e-71ae6c477d10	2025-06-12	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
DABIGATRAN	DABIGATRAN ETEXILATE	A-S Medication Solutions	e4e3b992-621a-43a5-be59-eeb5083fd2b4	2025-04-09	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045
Dabigatran Etexilate	DABIGATRAN ETEXILATE	XLCare Pharmaceuticals, Inc.	19b3bfc1-4fcb-4eb9-a611-02c27c05c56e	2023-08-15	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1037045

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 19 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
ba74e3cd-b06f-4145-b284-5fd6b84ff3c9	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	48	These highlights do not include all the information needed to use PRADAXA Capsules safely and effectively. See full prescribing information for PRADAXA Capsules. PRADAXA ® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 2010	20250625
3a8ec82a-c367-40dc-9302-e1896fcb05ea	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	26	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250917
a608e019-db9a-d6fb-cd0d-cecc1351a2b1	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	21	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250724
834a3c5f-b723-4bcb-a560-dc305dd0d829	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	13	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20251031
3c24e235-218b-438e-9456-42c18ff01913	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	8	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250730
80637981-d5a7-48cb-b7b2-f50807a8ab20	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	8	These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate) capsules, for oral use Initial U.S. Approval: 2010	20210616
6f79088b-b353-485a-9df4-6f5088f5bd0f	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	4	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20260206
baafb5be-ffe6-4755-a7ab-817b3c9b222d	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	4	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250730
dd47a015-ff90-d7a7-8dcb-4e6e31a68071	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	4	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN E TEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250626
13649035-a498-4e31-a7ea-8b18cedceca7	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	3	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20251120
5b196b1f-408e-4615-b980-9f822adff835	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	3	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250801
27e95caf-7938-ef8e-e063-6394a90a6a1a	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	2	DABIGATRAN ETEXILATE capsules, for oral use These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. Initial U.S. Approval: 2010	20260113
39ac558a-b375-f3c1-e063-6394a90aa901	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	2	DABIGATRAN ETEXILATE capsules, for oral use These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. Initial U.S. Approval: 2010	20251117
b76b79ce-b7dd-4390-b40e-71ae6c477d10	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	2	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250612
d5937f27-88c7-4c4a-801e-4c8945008982	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20251203
369b945d-5bda-4773-910a-d0adef7f0f39	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250919
e4e3b992-621a-43a5-be59-eeb5083fd2b4	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN ETEXILATE capsules, for oral use Initial U.S. Approval: 2010	20250409
19b3bfc1-4fcb-4eb9-a611-02c27c05c56e	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use DABIGATRAN ETEXILATE CAPSULES safely and effectively. See full prescribing information for DABIGATRAN ETEXILATE CAPSULES. DABIGATRAN etexilate capsules, for oral use Initial U.S. Approval: 2010	20230815
5db7f199-8752-4d24-85f7-e34ca8f4d02e	dabigatran etexilate 150 MG Oral Capsule [PSN] · dabigatran etexilate 150 MG Oral Capsule [SCD] · dabigatran etexilate 150 MG (dabigatran etexilate mesylate 172.95 MG) Oral Capsule [SY]	3	1	These highlights do not include all the information needed to use PRADAXA safely and effectively. See full prescribing information for PRADAXA. PRADAXA® (dabigatran etexilate mesylate) capsules for oral use Initial U.S. Approval: 2010	20101123